1.9 |
7.6 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
1.5 |
4.6 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
1.3 |
7.8 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
1.3 |
6.4 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
1.1 |
6.7 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
1.0 |
3.1 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
1.0 |
4.1 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
1.0 |
4.1 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
1.0 |
3.0 |
GO:0070668 |
positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
1.0 |
2.9 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
1.0 |
3.9 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
0.9 |
3.7 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
0.9 |
2.7 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
0.9 |
2.7 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.9 |
2.6 |
GO:0006267 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.8 |
3.2 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
0.7 |
0.7 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.7 |
2.1 |
GO:0051595 |
response to methylglyoxal(GO:0051595) |
0.7 |
5.6 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.7 |
0.7 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
0.7 |
4.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.6 |
3.8 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
0.6 |
7.6 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
0.6 |
1.9 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
0.6 |
1.9 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.6 |
2.5 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 |
1.6 |
GO:0051300 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.5 |
3.9 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
0.5 |
4.8 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.5 |
3.3 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
0.5 |
2.8 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 |
1.4 |
GO:0051311 |
meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
0.4 |
1.8 |
GO:0010165 |
response to X-ray(GO:0010165) |
0.4 |
1.8 |
GO:0000960 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 |
1.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
0.4 |
1.3 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.4 |
1.3 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 |
3.6 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
0.4 |
2.3 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
0.4 |
3.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
0.4 |
3.4 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
0.4 |
3.0 |
GO:0002759 |
regulation of antimicrobial humoral response(GO:0002759) |
0.4 |
1.1 |
GO:0090520 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.4 |
0.7 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
0.4 |
1.1 |
GO:0031587 |
detection of endogenous stimulus(GO:0009726) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 |
2.5 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 |
1.4 |
GO:0046833 |
snRNA export from nucleus(GO:0006408) positive regulation of RNA export from nucleus(GO:0046833) |
0.4 |
2.8 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 |
1.0 |
GO:0034093 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 |
1.7 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
0.3 |
1.0 |
GO:0072683 |
T cell extravasation(GO:0072683) |
0.3 |
2.4 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
0.3 |
1.0 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 |
0.7 |
GO:1901026 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 |
2.0 |
GO:0035709 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.3 |
0.9 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.3 |
1.6 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.3 |
9.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
0.3 |
3.1 |
GO:0032264 |
IMP salvage(GO:0032264) |
0.3 |
0.6 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 |
1.8 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.3 |
1.2 |
GO:1901804 |
beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.3 |
0.9 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
0.3 |
1.7 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
0.3 |
0.9 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
0.3 |
0.9 |
GO:1903609 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.3 |
0.9 |
GO:1900158 |
negative regulation of osteoclast proliferation(GO:0090291) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.3 |
1.7 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
0.3 |
3.6 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
0.3 |
1.1 |
GO:0021564 |
vagus nerve development(GO:0021564) |
0.3 |
1.4 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 |
2.8 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.3 |
0.8 |
GO:0099552 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.3 |
0.8 |
GO:2000269 |
fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 |
3.5 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 |
1.6 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 |
0.5 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) response to high density lipoprotein particle(GO:0055099) |
0.3 |
0.8 |
GO:1990637 |
response to prolactin(GO:1990637) |
0.3 |
1.3 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 |
0.8 |
GO:1900195 |
spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
0.3 |
2.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 |
0.7 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
0.2 |
6.3 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
0.2 |
1.2 |
GO:0044789 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 |
0.7 |
GO:0003220 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
0.2 |
0.7 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
0.2 |
1.6 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
0.2 |
0.7 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
0.2 |
2.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
0.2 |
0.9 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
0.2 |
3.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
0.2 |
1.3 |
GO:0034976 |
response to endoplasmic reticulum stress(GO:0034976) |
0.2 |
0.6 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
0.2 |
0.6 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.2 |
0.2 |
GO:2000018 |
regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
0.2 |
1.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
0.2 |
1.7 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 |
0.6 |
GO:0031392 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.2 |
1.4 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
0.2 |
0.6 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 |
0.6 |
GO:1905246 |
regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.2 |
3.2 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 |
1.4 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
0.2 |
0.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.2 |
1.8 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
0.2 |
5.6 |
GO:0061641 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 |
1.0 |
GO:0015862 |
uridine transport(GO:0015862) |
0.2 |
0.6 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 |
1.5 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 |
0.5 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
0.2 |
4.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
0.2 |
1.8 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 |
1.1 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
0.2 |
1.6 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
0.2 |
0.9 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.2 |
1.4 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 |
2.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
0.2 |
1.9 |
GO:2000582 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 |
1.7 |
GO:1903944 |
regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 |
0.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
0.2 |
0.2 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.2 |
2.0 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
0.2 |
1.0 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
0.2 |
0.6 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
0.2 |
0.5 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.2 |
0.6 |
GO:2000434 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 |
0.5 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 |
0.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
0.2 |
0.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
0.1 |
1.2 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
0.1 |
0.4 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
0.1 |
0.1 |
GO:0044843 |
G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 |
0.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.1 |
0.4 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
0.1 |
5.7 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 |
0.7 |
GO:0035549 |
positive regulation of interferon-beta secretion(GO:0035549) |
0.1 |
0.9 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 |
0.8 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
0.1 |
1.3 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 |
1.4 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
0.1 |
0.6 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
0.1 |
0.7 |
GO:1903911 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
0.1 |
0.7 |
GO:0071651 |
positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 |
0.4 |
GO:2000232 |
positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
0.1 |
1.9 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
0.1 |
0.5 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 |
0.4 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 |
1.4 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
0.1 |
0.8 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
0.1 |
1.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
0.1 |
2.3 |
GO:0016180 |
snRNA processing(GO:0016180) |
0.1 |
1.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
0.1 |
1.8 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
0.1 |
0.8 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 |
0.5 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
0.1 |
0.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
0.1 |
5.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
0.1 |
0.5 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
0.1 |
0.9 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
0.1 |
0.5 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
0.1 |
1.3 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 |
3.1 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 |
1.2 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
0.1 |
0.8 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 |
0.6 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 |
2.6 |
GO:0060148 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 |
0.2 |
GO:0051031 |
tRNA transport(GO:0051031) |
0.1 |
0.5 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
0.1 |
0.5 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
0.1 |
1.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
0.1 |
1.4 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
0.1 |
0.2 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 |
0.4 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
0.1 |
0.3 |
GO:0072402 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 |
0.9 |
GO:0097033 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 |
0.3 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 |
0.7 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
0.1 |
1.6 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
0.1 |
0.6 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
0.1 |
0.8 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
0.1 |
2.6 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
0.1 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
0.1 |
0.7 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 |
0.2 |
GO:0032607 |
interferon-alpha production(GO:0032607) |
0.1 |
2.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
0.1 |
0.4 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
0.1 |
0.5 |
GO:0061083 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 |
1.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
0.1 |
1.5 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
0.1 |
0.4 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) regulation of melanosome transport(GO:1902908) |
0.1 |
0.9 |
GO:0006983 |
ER overload response(GO:0006983) |
0.1 |
0.4 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
0.1 |
0.2 |
GO:0001812 |
positive regulation of type I hypersensitivity(GO:0001812) |
0.1 |
1.2 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
0.1 |
0.4 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) actin filament branching(GO:0090135) |
0.1 |
0.6 |
GO:0015824 |
proline transport(GO:0015824) |
0.1 |
0.6 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 |
1.7 |
GO:1901663 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 |
0.2 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
0.1 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
0.1 |
0.4 |
GO:2001140 |
regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 |
0.9 |
GO:0044597 |
polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 |
1.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
0.1 |
5.6 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 |
3.3 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
0.1 |
2.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
0.1 |
0.3 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
0.1 |
0.6 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 |
0.2 |
GO:1901376 |
mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.1 |
2.0 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 |
1.3 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
0.1 |
0.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
0.1 |
0.2 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 |
1.0 |
GO:0046051 |
UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 |
0.8 |
GO:0032202 |
telomere assembly(GO:0032202) |
0.1 |
0.6 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
0.1 |
0.7 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 |
2.7 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 |
0.9 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 |
0.7 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 |
0.2 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
0.1 |
0.2 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
0.1 |
0.3 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 |
2.3 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 |
0.7 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
0.1 |
0.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 |
0.2 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 |
0.6 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
0.1 |
0.3 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
0.1 |
0.3 |
GO:0043470 |
regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.1 |
0.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
0.1 |
0.6 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
0.1 |
0.3 |
GO:0001895 |
retina homeostasis(GO:0001895) |
0.1 |
0.2 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
0.1 |
0.6 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 |
0.8 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
0.1 |
0.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 |
0.4 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
0.1 |
0.9 |
GO:0021794 |
thalamus development(GO:0021794) |
0.1 |
0.3 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) regulation of kinetochore assembly(GO:0090234) |
0.1 |
0.3 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 |
0.4 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
0.1 |
3.3 |
GO:0006400 |
tRNA modification(GO:0006400) |
0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 |
0.2 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
0.1 |
0.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
0.1 |
0.6 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
0.1 |
1.5 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
0.1 |
0.3 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 |
0.7 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 |
0.5 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 |
0.2 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
0.1 |
0.3 |
GO:0003360 |
brainstem development(GO:0003360) |
0.1 |
0.5 |
GO:0045905 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 |
0.2 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 |
1.5 |
GO:0031114 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 |
0.5 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 |
0.7 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 |
0.9 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 |
0.2 |
GO:0060157 |
urinary bladder development(GO:0060157) |
0.1 |
0.4 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
0.1 |
0.2 |
GO:0019086 |
late viral transcription(GO:0019086) |
0.1 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 |
1.0 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 |
0.2 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
0.1 |
0.4 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 |
3.2 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 |
0.3 |
GO:0006953 |
acute-phase response(GO:0006953) |
0.0 |
0.5 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.0 |
0.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
0.0 |
0.6 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 |
0.5 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
0.0 |
0.7 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
0.0 |
1.0 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
0.0 |
0.3 |
GO:0009450 |
gamma-aminobutyric acid catabolic process(GO:0009450) |
0.0 |
0.2 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
0.0 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 |
0.4 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
0.0 |
0.7 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
0.0 |
0.2 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
0.0 |
0.5 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
0.0 |
0.0 |
GO:0071514 |
genetic imprinting(GO:0071514) |
0.0 |
0.5 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 |
0.9 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 |
1.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 |
1.1 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
0.0 |
1.4 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
0.0 |
0.6 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
0.0 |
0.1 |
GO:0051944 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 |
0.5 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
0.0 |
2.8 |
GO:0007265 |
Ras protein signal transduction(GO:0007265) |
0.0 |
0.4 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 |
0.3 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
0.0 |
0.5 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
0.0 |
0.3 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
0.0 |
0.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
0.0 |
1.5 |
GO:0009250 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 |
0.2 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
0.0 |
4.1 |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 |
0.8 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
0.0 |
2.4 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) negative regulation of protein depolymerization(GO:1901880) |
0.0 |
0.7 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 |
0.8 |
GO:0045056 |
transcytosis(GO:0045056) |
0.0 |
1.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 |
0.2 |
GO:0006415 |
translational termination(GO:0006415) |
0.0 |
0.2 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 |
0.7 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
0.0 |
0.5 |
GO:0006295 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 |
0.2 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 |
0.2 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
0.0 |
0.4 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
0.0 |
0.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
0.0 |
0.3 |
GO:0001302 |
replicative cell aging(GO:0001302) |
0.0 |
0.6 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
0.0 |
1.4 |
GO:0033146 |
regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 |
0.6 |
GO:0070723 |
response to cholesterol(GO:0070723) |
0.0 |
0.5 |
GO:0030100 |
regulation of endocytosis(GO:0030100) |
0.0 |
1.1 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
0.0 |
0.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
0.0 |
0.5 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 |
0.3 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
0.0 |
0.2 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
0.0 |
2.8 |
GO:0032481 |
positive regulation of type I interferon production(GO:0032481) |
0.0 |
0.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
0.0 |
0.9 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 |
1.5 |
GO:0002223 |
innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 |
0.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
0.4 |
GO:0051601 |
exocyst localization(GO:0051601) |
0.0 |
1.2 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
0.0 |
0.7 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 |
0.7 |
GO:0031639 |
plasminogen activation(GO:0031639) |
0.0 |
0.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
0.0 |
2.9 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
0.0 |
0.8 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
0.0 |
1.8 |
GO:0048278 |
vesicle docking(GO:0048278) |
0.0 |
2.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.0 |
0.1 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.0 |
0.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
0.0 |
0.9 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
0.0 |
0.1 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 |
1.0 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
0.0 |
0.1 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 |
0.5 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
0.0 |
0.1 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.0 |
0.4 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
0.0 |
0.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
0.0 |
0.2 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
0.0 |
0.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
0.0 |
0.0 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
0.0 |
0.2 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 |
0.2 |
GO:0030033 |
microvillus assembly(GO:0030033) |
0.0 |
0.2 |
GO:0042407 |
cristae formation(GO:0042407) |
0.0 |
0.1 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 |
0.1 |
GO:0061386 |
soft palate development(GO:0060023) closure of optic fissure(GO:0061386) |
0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
0.0 |
0.6 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 |
1.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
0.0 |
0.2 |
GO:0042723 |
thiamine-containing compound metabolic process(GO:0042723) |
0.0 |
0.5 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 |
0.4 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
0.0 |
0.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
0.0 |
0.3 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
0.0 |
0.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
0.0 |
0.1 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
0.0 |
0.2 |
GO:0021860 |
positive regulation of neuroblast proliferation(GO:0002052) pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 |
0.3 |
GO:0006954 |